Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diagnosing fatty liver disease: a comparative evaluation of metabolic markers, phenotypes, genotypes and established biomarkers.

PloS one - 1 Jan 2013

Siegert Sabine, Yu Zhonghao, Wang-Sattler Rui, Illig Thomas, Adamski Jerzy, Hampe Jochen, Nikolaus Susanna, Schreiber Stefan, Krawczak Michael, Nothnagel Michael, Nöthlings Ute

Abstract excerpt

BACKGROUND: To date, liver biopsy is the only means of reliable diagnosis for fatty liver disease (FLD). Owing to the inevitable biopsy-associated health risks, however, the development of valid noninvasive diagnostic tools for FLD is well warranted. AIM: We evaluated a particular metabolic profile with regard to its ability to diagnose FLD and compared its performance to that of established phenotypes,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endpoint Determination

Share to Fatty Liver

Share to Genotype

Share to Phenotype

Share to Sensitivity and Specificity

Source

Open in PubMed Open full text

Identifiers

PMID: 24130792
DOI: 10.1371/journal.pone.0076813
PMCID: PMC3793954

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diagnosing fatty liver disease: a comparative evaluation of metabolic markers, phenotypes, genotypes and established biomarkers.PMID 24130792Read ↗

[Precise clinical classification of metabolic associated fatty liver disease].Semantic proximity Read ↗

Prevalence of Significant and Advanced Hepatic Fibrosis in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)Semantic proximity Read ↗

Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset.Semantic proximity Read ↗

Biomarkers of NAFLD progression: a lipidomics approach to an epidemic.Semantic proximity Read ↗

Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean Population.Semantic proximity Read ↗

Evaluation of Liver Metabolism Biomarkers in Metabolic Associated Fatty Liver Disease According to Obesity Phenotype.Semantic proximity Read ↗

Is UA/HDL-C a Reliable Surrogate Marker for Fatty Liver? A Comparative Evaluation with Metabolic Scores in a Mexican Population: The Genetics of Atherosclerotic Disease StudySemantic proximity Read ↗

MASLD versus MAFLD in lean steatotic liver disease: diagnostic overlap, inclusivity, and the metabolically healthy lean phenotype.Semantic proximity Read ↗

Liver phenotypes in PCOS: Analysis of exogenous and inherited risk factors for liver injury in two European cohorts.Semantic proximity Read ↗

Plasma proteomic signature of fatty liver disease: The Rotterdam StudySemantic proximity Read ↗

Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis.Semantic proximity Read ↗

A metabolomics approach to the validation of predictive metabolites and phenotypic expression in non-alcoholic fatty liver disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.